Tumor-Derived Retinoic Acid Regulates Intratumoral Monocyte Differentiation to Promote Immune Suppression-Reference-Cited by-同舟云学术

Tumor-Derived Retinoic Acid Regulates Intratumoral Monocyte Differentiation to Promote Immune Suppression

Published:2020-03 Issue:6 Volume:180 Page:1098-1114.e16
ISSN:0092-8674
Container-title:Cell
language:en
Short-container-title:Cell

Author:

Devalaraja Samir,To Tsun Ki Jerrick,Folkert Ian W.,Natesan Ramakrishnan,Alam Md Zahidul,Li Minghong,Tada Yuma,Budagyan Konstantin,Dang Mai T.,Zhai Li,Lobel Graham P.,Ciotti Gabrielle E.,Eisinger-Mathason T.S. Karin,Asangani Irfan A.,Weber Kristy,Simon M. Celeste,Haldar Malay

Funder

Burroughs Wellcome Fund

National Cancer Institute

Concern Foundation

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference58 articles.

1. Comparative analysis of the efficiency and specificity of myeloid-Cre deleting strains using ROSA-EYFP reporter mice;Abram;J. Immunol. Methods,2014

2. β-catenin stabilization enhances SS18-SSX2-driven synovial sarcomagenesis and blocks the mesenchymal to epithelial transition;Barrott;Oncotarget,2015

3. All-trans retinoic acid induces arginase-1 and inducible nitric oxide synthase-producing dendritic cells with T cell inhibitory function;Bhatt;J. Immunol.,2014